References
- Boxenbaum B., D'Souza R. W. Interspecies pharmacokinetic scaling, biological design and neoteny. Advances in Drug Research, B. Testa. Academic Press Limited, London 1990; 139–196
- Boxenbaum H., Fertig J. B. Scaling of antipyrine intrinsic clearance of unbound drug in 15 mammalian species. European Journal of Drug Metabolism and Pharmacokinetics 1984; 9: 177–183
- Davies B., Morris T. Physiological parameters in laboratory animals and humans. Pharmaceutical Research 1993; 10: 1093–1095
- Dedrick R. L., Bischoff K. B., Zaharko D. S. Interspecies correlation of plasma concentrations of methotrexate (NSC-740). Cancer Chemotherapy Reports 1970; 54: 95–101
- Efthymiopoulos C., Battaglia R., Strolin-Benedetti M. Animal pharmacokinetics and interspecies scaling of FCE 22010, a penem antibiotic. Journal of Antimicrobial Chemotherapy 1991; 27: 517–526
- Heinzel G., Wobszczak R., Thomann P. Pharmacokinetic and Pharmacodynamic Data Analysis System for the PC. Gustav Fischer, Stuttgart 1993
- Hoener B. A. Predicting the hepatic clearance of xenobiotics in humans from in vitro data. Biopharmaceutics and Drug Disposition 1994; 15: 295–304
- Houston J. B. Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochemical Pharmacology 1994; 47: 1469–1479
- Lave T H., Coassolo P., Ubeaud G., Brandt R., Schmitt C., Dupin S., Jaeck D., Chou R. C. Interspecies scaling of bosentan, a new endothelin receptor antagonist and integration of in vitro data into allometric scaling. Pharmaceutical Research 1996; 13: 97–101
- Lave T H., Schmitt-Hoffmann A. H., Coassolo P., Ubeaud G., VallÈs B., BA B., Brandt R., Chou R. C. A new extrapolation method from animal to man; application to a metabolized compound, mofarotene. Life Sciences 1995; 56: 473–478
- Mordenti J. Man versus beast: pharmacokinetic scaling in mammals. Journal of Pharmaceutical Sciences 1986; 75: 1028–1040
- Mordenti J., Chen S. A., Moore J. A., Ferraiolo B. L., Green J. D. Interspecies scaling of clearance and volume of distribution data for five therapeutic proteins. Pharmaceutical Research 1991; 8: 1351–1359
- Pang K. S., Kong P., Terrell J. A., Billings R. E. Metabolism of acetaminophen and phenacetin by isolated rat hepatocytes. A system in which the spatial organization inherent in the liver is disrupted. Drug Metabolism and Disposition 1985; 13: 42–50
- Rane A., Wilkinson G. R., Shand D. G. Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance. Journal of Pharmacology and Experimental Therapeutics 1977; 200: 420–424
- Rowland M., Tozer T. Clinical Pharmacokinetics: Concepts and Applications. Philadelphia, London, Lea and Febiger 1989
- Sawada Y., Hanano M., Sugiyama Y., Iga T. Prediction of the disposition of beta-lactam antibiotics in humans from pharmacokinetic parameters in animals. Journal of Pharmacokinetics and Biopharmaceutics 1984; 12: 241–261
- Seddon T., Michelle I., Chenery R. J. Comparative drug metabolism of diazepam in hepatocytes isolated from man, rat, monkey and dog. Biochemical Pharmacology 1989; 38: 1657–1665
- Seglen P. P. Preparation of isolated rat liver cells. Methods in Cellular Biology 1976; 13: 29–83
- Swabb E. A., Bonner D. P. Prediction of aztreonam pharmacokinetics in humans based on data from animals. Journal of Pharmacokinetics and Biopharmaceutics 1983; 11: 215–223
- Ubeaud G., Schmitt C., Jaeck D., Lave T H., Coassolo P. Bosentan, a new endothelin receptor antagonist: Prediction of the systemic plasma clearance in man from combined in vivo and in vitro data. Xenobiotica 1995; 25: 1381–1390
- Zürcher G., Keller H. H., Kettler R., Borgulya J., Bonetti E. P., Eigenmann R., Da Prada M. Ro 40–7592, a novel, very potent and orally active inhibitor of catechol-O-methyltransferase: a pharmacological study in rats. Advances in Neurology 1990; 53: 497–503